Summary
In this short article for an Australian nursing magazine, New Zealand mental health nurse Jason Watson challenges the idea that withholding gender-affirming treatment from young people drives them to suicide. He looks at six large, long-term studies from the Netherlands, Sweden, Denmark, the UK and Finland. In his reading, suicide rates among transgender people stayed well above the general population after treatment, rates fell over time only for trans women in one Dutch study, and the Tavistock clinic review found no rise in youth suicides after access to puberty blockers was restricted in England. He concludes that the 'transition or suicide' claim is weak at best. The article was printed in July 2026, then removed from the journal's website after complaints; the nurses' union apologised for publishing it but later said this did not imply misconduct by the author. It is an opinion piece, not a systematic review: it picks a handful of studies, most of them about adults, and some of its readings go further than the studies' own authors. For example, the Finnish study it relies on most concluded that suicide risk was explained by mental illness and that gender reassignment did not change suicide risk either way.
Key findings
- Watson zpochybňuje často opakované tvrzení, že mladí lidé, kterým je odepřena léčba potvrzující pohlaví, mají vyšší riziko sebevraždy. Toto tvrzení uvádí WPATH i američtí zdravotničtí představitelé.
- Zhodnotil šest dlouhodobých sledovacích studií z Nizozemska, Švédska, Dánska, Velké Británie a Finska, které zahrnovaly od 324 do více než 15 000 lidí a sledování trvající od 5 do 46 let.
- Uvádí, že míra sebevražd a úmrtí mezi transgender lidmi zůstala po léčbě vyšší než v běžné populaci a že pouze jedna nizozemská studie zjistila pokles sebevražd v čase, a to u trans žen.
- Upozorňuje na přezkum sebevražd v anglické klinice Tavistock, který zjistil 12 sebevražd a žádný nárůst sebevražd mezi mladými po omezení blokátorů puberty, přestože se předpovídal prudký nárůst.
- Uzavírá, že narativ „tranzice, nebo sebevražda“ je „přinejmenším nepodložený a přinejhorším prostě nesprávný“, což odpovídá závěru Cassové zprávy, že většina výzkumu v této oblasti je nízké kvality.
- Australský odborový svaz sester odstranil článek z webu svého časopisu v červenci 2026 a omluvil se za jeho zveřejnění; později upřesnil, že nešlo o zjištění pochybení ze strany autora.
Abstract
This short article examines the narrative that trans youth who are not provided with gender-affirming healthcare face an increased risk of suicide, a view stated by WPATH's Standards of Care 8 and the US Assistant Secretary for Health in 2022. Noting the Cass Review's finding that research in this field is of poor quality, the author summarises six long-term follow-up studies from the Netherlands (Wiepjes 2020; de Blok 2021), Sweden (Dhejne 2011), Denmark (Erlangsen 2023), England (Appleby 2024, a review of suicides among Tavistock gender clinic patients) and Finland (Ruuska 2024), with sample sizes from 324 to 15,032 and follow-up from five to 46 years, and describes what each reported about suicide and mortality.
Conclusion
Only one finding, the decline in suicide among trans women over time in Wiepjes (2020), appeared to support the narrative that lack of access to gender-affirming care increases suicide risk. The author argues the other studies showed no evidence that treatment reduced suicidal behaviour, and reported higher 'other' mortality after treatment, and that Ruuska (2024), the only study with a matched control group, found much higher suicide and overall mortality among trans people. He concludes the 'trans suicide narrative' is 'at least tenuous and at most simply incorrect', consistent with the Cass Review's view that most research in this field is of poor quality.